Regenxbio
Price & Volume
Stats
See more52W Range | $5.45-$16.19 |
Market Cap | $472.6M |
Shares Short | 10M |
Financials
See moreRevenue (12 Mos) | $174.4M |
Revenue Growth (YoY) | 405.7% |
Gross Profit (12 Mos) | -$78.4M |
Diluted EPS | -$3.78 |
News
See moreYahoo Finance • 23 days ago
REGENXBIO to Host Investor Event Highlighting Surabgene Lomparvovec (Sura-vec) in Wet AMD on October 20
Yahoo Finance • last month
REGENXBIO Presents Positive Three-Year Durability Data for Surabgene Lomparvovec in Diabetic Retinopathy at Retina Society Annual Scientific Meeting
Yahoo Finance • 2 months ago
RGNX Stock Slumps 25% on FDA Clinical Hold for RGX-121 Gene Therapy
Yahoo Finance • 2 months ago
Why Regenxbio Halted Its Gene Therapy Trial—and Why the Stock Is Tumbling
About
CEO | Mr. Curran M. Simpson M.S. |
CFO | Mr. Mitchell Chan M.B.A. |
Address | 9804 Medical Center Drive, Rockville, MD, United States, 20850 |
Sector | Healthcare |
Industry | Biotechnology |
Full-Time Employees | 371 |